Literature DB >> 9230112

The cluster of basic amino acids in vitronectin contributes to its binding of plasminogen activator inhibitor-1: evidence from thrombin-, elastase- and plasmin-cleaved vitronectins and anti-peptide antibodies.

Z Gechtman1, A Belleli, S Lechpammer, S Shaltiel.   

Abstract

Derivatives of vitronectin obtained by specific cleavage at its cluster of basic amino acids with thrombin, elastase and plasmin are shown to have a decreased ability to bind plasminogen activator inhibitor-1 (PAI-1). The identification and localization of the segment involved in the binding of PAI-1 (Lys348-Arg379) were carried out by purification of these cleaved vitronectins and their subsequent structural characterization (sequence analysis, phosphorylation of Ser378 with cAMP-dependent protein kinase and immunostaining with peptide-specific antibodies), then measurement of the vitronectin-PAI-1 interaction by (a) a two-phase system (ELISA); (b) co-precipitation of the vitronectin-PAI-1 complex out of solution, and (c) analysis of the stereospecific interaction between the active conformation of PAI-1 and a peptide derived from the above-mentioned cluster; this interaction occurs when the peptide is composed of all-l-amino acids but not when it is composed of all-d-amino acids. Our results explain why workers who have used immobilized vitronectin to study this interaction could not have observed the involvement of the cluster of basic amino acids in PAI-1 binding, since the immobilization of vitronectin is shown to render this cluster inaccessible for interaction. We propose that vitronectin binds active PAI-1 by interaction via amino acid residues that originate from distal locations in the N- and C-termini of vitronectin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230112      PMCID: PMC1218566          DOI: 10.1042/bj3250339

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  57 in total

Review 1.  Structure and biological role of vitronectin.

Authors:  K T Preissner
Journal:  Annu Rev Cell Biol       Date:  1991

2.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 3.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

4.  Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin. Use in mapping the PAI-1 binding site.

Authors:  Z Gechtman; R Sharma; T Kreizman; M Fridkin; S Shaltiel
Journal:  FEBS Lett       Date:  1993-01-11       Impact factor: 4.124

Review 5.  Atherogenesis and inflammation.

Authors:  I K Jang; R Lassila; V Fuster
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

6.  Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin.

Authors:  J Mimuro; S Muramatsu; Y Kurano; Y Uchida; H Ikadai; S Watanabe; Y Sakata
Journal:  Biochemistry       Date:  1993-03-09       Impact factor: 3.162

Review 7.  Vitronectin and its receptors.

Authors:  B Felding-Habermann; D A Cheresh
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

8.  The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.

Authors:  D Seiffert; G Ciambrone; N V Wagner; B R Binder; D J Loskutoff
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

9.  Heparin mediates binding of S-protein/vitronectin to the envelope glycoprotein of the human immunodeficiency virus and CD4.

Authors:  H R Su; R J Boackle
Journal:  Int Arch Allergy Immunol       Date:  1994-11       Impact factor: 2.749

10.  Identification of a PAI-1 binding site in vitronectin.

Authors:  O Sigurdardottir; B Wiman
Journal:  Biochim Biophys Acta       Date:  1994-09-21
View more
  4 in total

Review 1.  Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Authors:  Salvador Eugenio C Caoili
Journal:  J Biomed Biotechnol       Date:  2010-03-30

2.  HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.

Authors:  Guadalupe Ortiz-Muñoz; Xavier Houard; Jose-Luis Martín-Ventura; Brian Y Ishida; Stéphane Loyau; Patrick Rossignol; Juan-Antonio Moreno; John P Kane; Robert J Chalkley; Alma L Burlingame; Jean-Baptiste Michel; Olivier Meilhac
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

3.  Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation.

Authors:  Sheryl R Bowley; Chao Fang; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Commun       Date:  2017-02-20       Impact factor: 14.919

Review 4.  Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.

Authors:  Machteld Sillen; Paul J Declerck
Journal:  Front Cardiovasc Med       Date:  2020-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.